We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

77 hedge funds and large institutions have $106M invested in Kindred Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

36% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 22

3% more funds holding

Funds holding: 7577 (+2)

52% less capital invested

Capital invested by funds: $220M → $106M (-$114M)

Holders
77
Holders Change
+2
Holders Change %
+2.67%
% of All Funds
1.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
30
Reduced
22
Closed
8
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
-$146K
Name Holding Trade Value Shares
Change
Change in
Stake
TWA
76
TCI Wealth Advisors
Arizona
$1K -$662 -78 -28%
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
-$471K -55,500 Closed
Millennium Management
78
Millennium Management
New York
-$401K -47,303 Closed
Squarepoint
79
Squarepoint
New York
-$348K -41,086 Closed
MWNA
80
Marshall Wace North America
New York
-$59K -6,910 Closed
Simplex Trading
81
Simplex Trading
Illinois
-$35.1K -4,128 Closed
MAM
82
Meeder Asset Management
Ohio
-$16K -1,837 Closed
HF
83
Halpern Financial
Virginia
-$4.24K -500 Closed
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
-$4K -426 Closed

KIN Hedge Fund Activity: Q1 2020 in Review

77 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q1 2020, worth a combined $106M — down 52% from $220M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new KIN positions and 8 closed out — a net gain of 4 holders — while 30 added to existing stakes and 22 trimmed.

The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $2.46M. The largest seller was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, cutting an estimated $510K.

  • 77 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q1 2020, up from 75 in Q4 2019.
  • Funds reported $106M of Kindred Biosciences, Inc. stock for Q1 2020, down 52% quarter-over-quarter.
  • 12 funds opened new Kindred Biosciences, Inc. positions in Q1 2020 and 8 closed out, a net change of +4 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q1 2020 was Assenagon Asset Management, an estimated $2.46M added.
  • The largest Kindred Biosciences, Inc. seller in Q1 2020 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $510K sold.

Based on aggregated 13F filings for Q1 2020.